<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5722">
    <title>DSpace Collection:</title>
    <link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5722</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5723" />
      </rdf:Seq>
    </items>
    <dc:date>2026-05-05T09:47:52Z</dc:date>
  </channel>
  <item rdf:about="https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5723">
    <title>Effect of 1,25-(OH)2D3 on pathophysiology of heart,  aorta and lungs in male albino rats exposed to  chromium(VI)</title>
    <link>https://digitallibrary.bldedu.ac.in/xmlui/handle/123456789/5723</link>
    <description>Title: Effect of 1,25-(OH)2D3 on pathophysiology of heart,  aorta and lungs in male albino rats exposed to  chromium(VI)
Authors: Yendigeri, Saeed M.
Abstract: ABSTRACT &#xD;
Introduction: Exposure to heavy metal Cr(VI) causes generation of free radicals, &#xD;
induction of oxidative and nitrosative stress with depletion of antioxidants leading to &#xD;
sequels of cell injury. Fat-soluble 1,25(OH)2D3 is an anti-oxidant capable of reducing &#xD;
noxious effects of oxidative and nitrosative stress caused by Cr-induced generation of &#xD;
reactive oxygen and nitrogen free radicles. &#xD;
Objective: The present study was aimed to evaluate potential role of 1,25(OH)2D3 as an &#xD;
antioxidant against Cr(VI)-induced toxicities in the heart, aorta and lung of &#xD;
experimental animals. &#xD;
Methods: The experimental animals consisted of twenty-four laboratory bred adult &#xD;
male Wistar strain of albino rats, weighing between 180 to 220  grams, which were &#xD;
randomly sorted into four equal groups; each with six rats. Group-1 served as a control &#xD;
with no interventions. Group-2 was exposed to K2Cr2O7 intraperitoneally in a dose of &#xD;
0.5 mg/kg body weight on alternative days. Group-3 was supplemented with &#xD;
1,25(OH)2D3 orally in a dose of 12.5 µg/kg daily. Group-4 was given combined &#xD;
K2Cr2O7 and 1,25(OH)2D3 simultaneously with respective doses and routes. The &#xD;
intervention was carried for 21 days. Gravimetry (body weight) and cardiac &#xD;
electrophysiologic analysis (ECG, MAP and HRV) was done pre (Day-1) and post &#xD;
(Day-21) -interventions. During the course of intervention blood sugar was estimated &#xD;
on day-1, 7, 14 &amp; 21. After 21-days of interventions, rats were fasted for 10 hours &#xD;
during the night. Collection of blood samples followed by sacrifice of the rats and &#xD;
collections of tissue specimens of heart, aorta, lungs and liver was carried out on day&#xD;
22. &#xD;
Results: After 21 days of individual treatments, statistically significant impairments &#xD;
were observed. The Group-2 (K2Cr2O7-exposed) had a significant impairment in; &#xD;
gravimetry (loss of body weight and increased organosomatic index), cardiac &#xD;
autonomic functions (increased sympathetic and decreased parasympathetic causing &#xD;
[1] &#xD;
vasovagal imbalance), hemodynamic (increased HR, MAP, altered HRV) hematologic &#xD;
(reduced Hb, red cell indices, Plt, and increased TLC), glucose homeostasis (increased &#xD;
FBG, OGTT, decreased plasma insulin, increased insulinogenic index and decreased &#xD;
liver glycogen), lipid profile (decreased TC, TGL, LDL and decreased HDL), LFT &#xD;
(increased serum- bilirubin,  SGOT, SGPT, ALP, decreased protein and albumin), &#xD;
serum oxidative stress (increased serum MDA), tissue oxidative stress (increased tissue &#xD;
LPO in heart, aorta and lungs), nitrosative stress (increased serum NO), antioxidative &#xD;
markers (deceased SOD, vitamin- C, D &amp; E), molecular marker (increased serum &#xD;
VEGF), chromium (increased serum chromium), histopathogic (morphologic tissue &#xD;
remodeling of heart, aorta and lung tissues) and NWI (increased in coronary arteries &#xD;
and aorta). Supplementation of 1,25(OH)2D3 ameliorated the respective parameters. &#xD;
Conclusion: The results clearly substantiate that chromium-toxicity enhanced the &#xD;
generation of ROS and NOS, causing oxidative and nitrosative stress and affecting &#xD;
pathophysiologic changes in cardiovascular and pulmonary system in male albino rats. &#xD;
It was manifested with cardiac sympathetic over activity and parasympathetic under&#xD;
drive, vasovagal imbalance, hypertension,  impaired glucose homeostasis, metabolic, &#xD;
oxidative and nitrosative stress synchronously deprivation of antioxidants, up&#xD;
regulation of vascular functions and tissue remodeling. Supplementation of &#xD;
1,25(OH)2D3 brought ameliorating reduction in sympathetic over-activity; MAP; &#xD;
metabolic, oxidative and nitrosative stress, cardiovascular and pulmonary remodeling. &#xD;
These effects of 1,25(OH)2D3 could be attributed to its antioxidant property which can &#xD;
possibly be explored as an adjuvant in therapy against Cr(VI) induced toxicity in &#xD;
humans.</description>
    <dc:date>2024-01-01T00:00:00Z</dc:date>
  </item>
</rdf:RDF>

